Ha, funny, I was just reviewing that myself, casually said but they are the words. ‘Huge dent in cancer’. Hope she hadn’t just had one to many glasses of champagne, we’ve all been there.
Or they have got rid of the cln issue so that the share prices can appreciate after some news rather than having a certain part of the investment community carping on about it ad infinitum post data/news. The up and coming data takes us very much into the partnership window for 6000. Without the cln over hang it’s hard to know what the pub bore and Derek will find the drone on about. Alas I’m sure they will!
Touk, rather than having my posts pointing out your lack of research removed, perhaps spend that time reading and listening to and watching company communications.
RE: Breakthrough ovarian cancer drug offers patients more time and better quality of life4 Jun 2026 18:13
That’s hilarious Touk, please do go back through my posts I rarely hype or ramp or deramp. Just comment on proceedings and correct your and others weak fud occasionally.
You didn’t answer my question though. Do you think it’s wise to comment on a share of which you don’t keep abreast of major company communications? Or even be invested?
RE: Breakthrough ovarian cancer drug offers patients more time and better quality of life4 Jun 2026 09:31
Nasty.. like calling someone insane? Get a grip Touk, I. am now seriously doubting you are invested at all. How many shares have you got? And you don’t even watch company presentations yet carp on about them endlessly on a bullitin board. It doesn’t add up.
It was the last presentation. Look it up in the website. To be honest if you are invested to the point that you claim to be and spend such a large amount of time on here spouting off about avacta ,I’m frankly flabbergasted that you don’t watch these presentations. Surely someone of your financial acumen keeps abreast of their investments presentations and updates.